
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic targeting of non-coding RNAs in cancer
Ondřej Slabý, Richard Laga, Ondřej Sedláček
Biochemical Journal (2017) Vol. 474, Iss. 24, pp. 4219-4251
Closed Access | Times Cited: 240
Ondřej Slabý, Richard Laga, Ondřej Sedláček
Biochemical Journal (2017) Vol. 474, Iss. 24, pp. 4219-4251
Closed Access | Times Cited: 240
Showing 1-25 of 240 citing articles:
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Lu Zhang, Yi Liao, Liling Tang
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 440
Lu Zhang, Yi Liao, Liling Tang
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 440
Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue
Rui-Sheng Zhou, Enxin Zhang, Qinfeng Sun, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 292
Rui-Sheng Zhou, Enxin Zhang, Qinfeng Sun, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 292
Gut Reactions: Breaking Down Xenobiotic–Microbiome Interactions
Gerard Clarke, Kiran V. Sandhu, Brendan T. Griffin, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 198-224
Open Access | Times Cited: 272
Gerard Clarke, Kiran V. Sandhu, Brendan T. Griffin, et al.
Pharmacological Reviews (2019) Vol. 71, Iss. 2, pp. 198-224
Open Access | Times Cited: 272
RNAi-based therapeutics and tumor targeted delivery in cancer
Göknur Kara, George A. Călin, Bülent Özpolat
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114113-114113
Closed Access | Times Cited: 262
Göknur Kara, George A. Călin, Bülent Özpolat
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114113-114113
Closed Access | Times Cited: 262
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
Barbara Pardini, Alexandru A. Sabo, Giovanni Birolo, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1170-1170
Open Access | Times Cited: 179
Barbara Pardini, Alexandru A. Sabo, Giovanni Birolo, et al.
Cancers (2019) Vol. 11, Iss. 8, pp. 1170-1170
Open Access | Times Cited: 179
The roles of exosomal miRNAs and lncRNAs in lung diseases
Li Yang, Zhengrong Yin, Jinshuo Fan, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 171
Li Yang, Zhengrong Yin, Jinshuo Fan, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 171
Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer
Xin Lai, Martin Eberhardt, Ulf Schmitz, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 15, pp. 7753-7766
Open Access | Times Cited: 161
Xin Lai, Martin Eberhardt, Ulf Schmitz, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 15, pp. 7753-7766
Open Access | Times Cited: 161
Long non-coding RNA mediated drug resistance in breast cancer
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 99
Deepshikha Singh, Yehuda G. Assaraf, Rajesh N. Gacche
Drug Resistance Updates (2022) Vol. 63, pp. 100851-100851
Closed Access | Times Cited: 99
Non-coding RNAs and ferroptosis: potential implications for cancer therapy
Amar Balihodzic, Felix Prinz, Michael A. Dengler, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1094-1106
Open Access | Times Cited: 98
Amar Balihodzic, Felix Prinz, Michael A. Dengler, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1094-1106
Open Access | Times Cited: 98
Mechanisms Contributing to the Comorbidity of COPD and Lung Cancer
Aisling Forder, Rebecca Zhuang, Vanessa G. P. Souza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2859-2859
Open Access | Times Cited: 49
Aisling Forder, Rebecca Zhuang, Vanessa G. P. Souza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2859-2859
Open Access | Times Cited: 49
Long non‐coding RNAs in cancer: Another layer of complexity
Jaqueline Carvalho de Oliveira, Luana Caroline Oliveira, Carolina Mathias, et al.
The Journal of Gene Medicine (2018) Vol. 21, Iss. 1
Closed Access | Times Cited: 109
Jaqueline Carvalho de Oliveira, Luana Caroline Oliveira, Carolina Mathias, et al.
The Journal of Gene Medicine (2018) Vol. 21, Iss. 1
Closed Access | Times Cited: 109
Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
Monica Cantile, Maurizio Di Bonito, Margherita Cerrone, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1197-1197
Open Access | Times Cited: 96
Monica Cantile, Maurizio Di Bonito, Margherita Cerrone, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1197-1197
Open Access | Times Cited: 96
Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis
Yuanliang Yan, Zhijie Xu, Xi Chen, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 89
Yuanliang Yan, Zhijie Xu, Xi Chen, et al.
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 89
miR‐211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma
Fangfang Tao, Xinxin Tian, Shanming Ruan, et al.
The FASEB Journal (2018) Vol. 32, Iss. 11, pp. 6330-6343
Open Access | Times Cited: 86
Fangfang Tao, Xinxin Tian, Shanming Ruan, et al.
The FASEB Journal (2018) Vol. 32, Iss. 11, pp. 6330-6343
Open Access | Times Cited: 86
Lipid nanocarriers for microRNA delivery
Marcel Scheideler, Ivan Vidaković, Ruth Prassl
Chemistry and Physics of Lipids (2019) Vol. 226, pp. 104837-104837
Closed Access | Times Cited: 82
Marcel Scheideler, Ivan Vidaković, Ruth Prassl
Chemistry and Physics of Lipids (2019) Vol. 226, pp. 104837-104837
Closed Access | Times Cited: 82
MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics
Daniel Jakubik, Alex Fitas, Ceren Eyileten, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 74
Daniel Jakubik, Alex Fitas, Ceren Eyileten, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 74
Development of MicroRNAs as Potential Therapeutics against Cancer
Noraini Abd-Aziz, Nur Izyani Kamaruzman, Chit Laa Poh
Journal of Oncology (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 73
Noraini Abd-Aziz, Nur Izyani Kamaruzman, Chit Laa Poh
Journal of Oncology (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 73
Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression
Yingying Xing, Guojing Ruan, Haiwei Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Yingying Xing, Guojing Ruan, Haiwei Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
A systematic review of the research progress of non-coding RNA in neuroinflammation and immune regulation in cerebral infarction/ischemia-reperfusion injury
Kailin Yang, Liuting Zeng, Anqi Ge, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 61
Kailin Yang, Liuting Zeng, Anqi Ge, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 61
LncRNAs in breast cancer: a link to future approaches
Nikolaos Sideris, Paola Dama, Salih Bayraktar, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 12, pp. 1866-1877
Open Access | Times Cited: 51
Nikolaos Sideris, Paola Dama, Salih Bayraktar, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 12, pp. 1866-1877
Open Access | Times Cited: 51
R-BIND 2.0: An Updated Database of Bioactive RNA-Targeting Small Molecules and Associated RNA Secondary Structures
Anita Donlic, Emily G. Swanson, Liang‐Yuan Chiu, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 6, pp. 1556-1566
Open Access | Times Cited: 49
Anita Donlic, Emily G. Swanson, Liang‐Yuan Chiu, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 6, pp. 1556-1566
Open Access | Times Cited: 49
Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications
Yanjun Zhang, Lijuan Zhan, Xue Jiang, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116218-116218
Closed Access | Times Cited: 16
Yanjun Zhang, Lijuan Zhan, Xue Jiang, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116218-116218
Closed Access | Times Cited: 16
Nanomaterials‐Based Targeting of Long Non‐Coding RNAs in Cancer: A Cutting‐Edge Review of Current Trends
Fatemeh Davodabadi, Bahareh Farasati Far, Saman Sargazi, et al.
ChemMedChem (2024) Vol. 19, Iss. 8
Closed Access | Times Cited: 12
Fatemeh Davodabadi, Bahareh Farasati Far, Saman Sargazi, et al.
ChemMedChem (2024) Vol. 19, Iss. 8
Closed Access | Times Cited: 12
Non-Coding RNA: A Key Regulator in the Glutathione-GPX4 Pathway of Ferroptosis
Md Sadique Hussain, Gaurav Gupta, Moyad Shahwan, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1222-1234
Open Access | Times Cited: 10
Md Sadique Hussain, Gaurav Gupta, Moyad Shahwan, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 4, pp. 1222-1234
Open Access | Times Cited: 10
LncRNAs as Chromatin Regulators in Cancer: From Molecular Function to Clinical Potential
Rodiola Begolli, Nikolaos Sideris, Antonis Giakountis
Cancers (2019) Vol. 11, Iss. 10, pp. 1524-1524
Open Access | Times Cited: 76
Rodiola Begolli, Nikolaos Sideris, Antonis Giakountis
Cancers (2019) Vol. 11, Iss. 10, pp. 1524-1524
Open Access | Times Cited: 76